Finland· FI-REL-REL45111

Canor Vet

A deksametasoni ja mikrobilääkkeet product containing marbofloxacin + clotrimazole + dexamethasone, registered in Finland by Norbrook Laboratories Limited. The same ATC class is registered in 2 of our 19 countries.

ATC QS02CA06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedCanor VetATCQS02CA06REGISTER NO.FI-REL-REL45111PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Marbofloxacin + clotrimazole + dexamethasone is registered in 2 of 19 countries.

Countries holding a registration under ATC QS02CA06 (deksametasoni ja mikrobilääkkeet), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Marbofloxacin + clotrimazole + dexamethasone · ATC QS02CA06

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Marbofloxacin + Clotrimazole + Dexamethasone
Manufacturer
Norbrook Laboratories Limited
Country
Finland (FI)
ATC code
QS02CA06
ATC class
Deksametasoni ja mikrobilääkkeet
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Marbofloxacin + clotrimazole + dexamethasone in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All marbofloxacin + clotrimazole + dexamethasone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed6ddd58-1510-4379-8a3d-ad57e4d995dc
GET /v1/drugs/ed6ddd58-1510-4379-8a3d-ad57e4d995dc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "korvatipat, suspensio",
  "route": "Topical",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Deksametasoni ja mikrobilääkkeet",
  "ma_number": "32186",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL45111",
  "authorised_at": "2016-06-09"
}

See everything about marbofloxacin + clotrimazole + dexamethasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.